$0.255
+0.002 (+0.83%)終値時点
価格予想
アプリで開くと、より長期の予想を確認できます。
類似チャート分析による VTGN の予測・予想
Alphio's VTGN stock price prediction model matches the current Vistagen Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.26 (+0.43%). The 1-week path is $0.25 (-1.38%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Vistagen Therapeutics Inc 株は買うべき？
Vistagen Therapeutics is currently not a strong buy. The stock is trading at $0.2529, and while it has shown a 3.65% increase over the past five days, it has a staggering year-to-date decline of 62.75%. The RSI is at 48.935, indicating a neutral position, and the forward P/E ratio is 0, reflecting uncertainty in future earnings. The main risk is the recent trial failure which caused a significant drop in stock price, highlighting potential volatility ahead.
VTGN の株価は Monday に $0.26 で引け、その前に上昇 +0.83%
Vistagen Therapeutics Inc (VTGN) last closed at $0.255, gaining +0.83%. These facts feed the 1-day and 1-week VTGN price prediction above.
アナリストのコンセンサス
Vistagen Therapeutics Inc（VTGN）：買い 1、中立 0、売り 0。見通し：Strong Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
予想の要因
Vistagen Therapeutics Inc（VTGN）の予想は、類似したチャートパターン・季節性・移動平均を組み合わせています。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
類似チャートパターン
直近の値動きが VTGN に最も近い銘柄を、類似度順に表示します。
VTGN の季節性分析
Historically the probability of a positive September return for VTGN is 38.10%. October offers the highest probability of a positive month at 50.00%, while May is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。